Monday, February 11, 2008

BLOGSCAN - Contrasting Approaches to Commercial Funding of CME

On the Carlat Psychiatry Blog, Dr Daniel Carlat contrasted approaches to commercial funding of continuing medical education (CME) at two different academic medical centers. His earlier post noted that at Sloan-Kettering in New York, commercial funding of CME has been banned. On the other hand, his next post noted that at the Massachusetts General Hospital in Boston, the psychiatry department developed the "MGH Psychiatry Academy," to actively solicity big-time money from pharmaceutical companies. Whose programs will feature fancier venues, better food, and more high-tech graphics? Whose programs would you trust more?


Anonymous said...

I am tired of programs that basically feature one product. It's marketing in the costume of CME. I would rather attend programs that are genuinely broad-based, and while I am not involved in oncology it sounds like sloan-kettering is taking a novel step towards scientific robustness. I hope it works.

Anonymous said...

Appears to be conflcting posts by Dr. Carlat, which I'd be happy for him to explain his unclear stance and clouded objectivity on the matters in his posts illustrated in this one.